Related Experiment Videos
What type of eye drops should be given to a toddler with conjunctivitis?
1Graduate Studies, School of Nursing and Midwifery, King's College, London. peter.griffiths@kcl.ac.uk
Insights
Fusidic acid eye drops and chloramphenicol show similar effectiveness for conjunctivitis. However, fusidic acid may be preferred due to better tolerability and higher efficacy in some regions.
Area of Science:
- Ophthalmology
- Pharmacology
- Evidence-Based Medicine
Background:
- Conjunctivitis is a common eye infection requiring effective treatment.
- Fusidic acid eye drops and chloramphenicol are frequently prescribed therapies.
- A parent sought to rapidly evaluate the comparative efficacy and tolerability of these treatments.
Purpose of the Study:
- To review the available evidence comparing fusidic acid eye drops and chloramphenicol for conjunctivitis treatment.
- To assess the relative effectiveness and safety of these two common ophthalmic preparations.
Main Methods:
- A rapid mini-review of literature was performed using free online databases (PubMed, Cochrane Library).
- Only abstracts of identified papers were accessed within a limited timeframe.
- Five studies comparing fusidic acid eye drops to chloramphenicol were included.
Main Results:
- Three studies found no significant difference in effectiveness between fusidic acid and chloramphenicol.
- Two studies from less-developed countries indicated superior efficacy for fusidic acid.
- Chloramphenicol demonstrated lower tolerability in some comparative studies.
Conclusions:
- Fusidic acid eye drops may be the preferred treatment for conjunctivitis due to potentially better tolerability and demonstrated higher efficacy in specific populations.
- Rapid evidence synthesis is feasible for clinical decision-making even with limited resources.
- Further research may be warranted to clarify optimal treatment strategies in diverse settings.
Abstract:
This mini-review describes a parent's search for evidence on the relative merits of two commonly used treatments for conjunctivitis. It was conducted in a very limited period of time with access to free databases (Pub Med, Cochrane Library) and only the abstracts of papers. Five relevant studies were identified that compared fusidic acid eye drops to chloramphenicol. Three of the five studies reported no difference in effectiveness between the two preparations with both drugs performing equally well. Two studies undertaken in less-developed countries showed fusidic acid to be far more effective but the cure rate with chloramphenicol was low, suggesting resistance or different causal agents. However, there was some evidence that chloramphenicol was less well tolerated and so fusidic acid may be the drug of choice. The review illustrates that evidence for practice can be found rapidly with access to limited facilities by an appropriately skilled practitioner.